Merck & Co., Inc. (NYSE: MRK) is one of the stocks Jim Cramer discussed, along with the tech battleground. Cramer highlighted the company’s strategic planning for when Keytruda loses patent protection ...
This degree of success can become a double-edged sword, though. While the drug has thrived since its first approval back in ...
With yields between 3.4% and 6.8%, you'll need to think carefully about the highest yields in the Dow before you buy them.
Kennedy’s advisers scrap hepatitis B vaccine guidance for most children in major policy shift – Nation and World News | West Hawaii Today ...
If you own or are considering buying pharma laggards Pfizer (NYSE: PFE), Bristol Myers Squibb (NYSE: BMY), and Merck (NYSE: ...
Finally, Merck is an excellent dividend stock. It offers a juicy forward yield of 3.2% and has increased its payouts by 93.8% ...
An influential panel of US vaccine advisers voted to revoke a longstanding recommendation that all babies receive hepatitis B shots within 24 hours of birth.
The world's first single-dose vaccine to prevent dengue fever has been approved for licensure in one of the largest countries ...
Halozyme is seeing some progress in its global effort to defend intellectual property against alleged infringement by Merck & ...
3d
These Are the 3 Hottest Stocks in the S&P 500 Heading Into the New Year. Should You Invest in Them?
I've identified three stocks in the S&P 500 index that look like variations on that narrative, and they happen to be the ...
In a setback for Merck, a German court issued a preliminary injunction that prevents the company from distributing a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results